Riggs Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
Riggs Asset Management's INO Position: Q4 2022 in Review
Riggs Asset Management sold out of Inovio Pharmaceuticals (INO) in Q4 2022, closing a stake of 10 shares.
Riggs Asset Management first reported a position in INO in Q4 2014 and held it in 31 quarters. The position peaked at $3K in Q2 2020. 183 funds tracked by Wall St. Rank hold INO as of Q4 2022.
- Riggs Asset Management reported no remaining Inovio Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Riggs Asset Management sold 10 Inovio Pharmaceuticals shares in Q4 2022.
- Riggs Asset Management first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 31 quarters.
- Riggs Asset Management's Inovio Pharmaceuticals position peaked at $3K in Q2 2020.
- 183 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2022.
Based on Riggs Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.